Achieve Life Sciences Inc... (ACHV)
NASDAQ: ACHV
· Real-Time Price · USD
2.54
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:59 PM
2.46
-3.34%
After-hours: Aug 15, 2025, 07:49 PM EDT
Achieve Life Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 57K | 114K | 171K | 271K | 314K | 257K | 265K | 220K | 176K | 236K | 233K | 239K | 246K | 250K | 188K | 127K | 64K |
Gross Profit | -57K | -114K | -171K | -271K | -314K | -257K | -265K | -220K | -176K | -236K | -233K | -239K | -246K | -250K | -188K | -127K | -64K |
Operating Income | -20.65M | -26.63M | -18.83M | -25.4M | -24.65M | -27.25M | -33.73M | -39.75M | -42.1M | -40.75M | -37M | -31.1M | -32.34M | -33.1M | -30.71M | -27.77M | -19.38M |
Interest Income | 2.31M | 2.36M | 2.08M | 1.67M | 1.03M | 825K | 735K | 546K | 357K | 199K | 84K | 14K | 13K | 17K | 36K | 35K | 35K |
Pretax Income | -46.16M | -39.83M | -32.94M | -27.54M | -27.32M | -29.82M | -35.57M | -41.54M | -43.77M | -42.35M | -38.27M | -31.88M | -32.73M | -33.15M | -30.73M | -27.8M | -19.41M |
Net Income | -46.16M | -39.83M | -32.94M | -27.54M | -27.32M | -29.82M | -35.33M | -41.78M | -44.41M | -43.34M | -39.5M | -32.63M | -33.07M | -33.15M | -30.73M | -27.8M | -19.41M |
Selling & General & Admin | 18.87M | 16.2M | 13.52M | 11.65M | 11.46M | 11.38M | 11.41M | 11.19M | 10.93M | 10.72M | 11.08M | 10.41M | 9.62M | 9.13M | 8.89M | 8.65M | 8.39M |
Research & Development | 27.11M | 22.82M | 17.64M | 13.61M | 13.08M | 15.81M | 22.31M | 28.6M | 31.22M | 30.08M | 25.97M | 20.69M | 22.71M | 23.97M | 21.81M | 19.11M | 10.98M |
Other Expenses | -2K | -17K | n/a | -17K | -540K | -525K | -542K | -555K | -25K | -19K | -55K | -26K | -43K | -64K | -53K | -62K | -57K |
Operating Expenses | 45.98M | 39.01M | 31.15M | 25.26M | 24.54M | 27.19M | 33.73M | 39.79M | 42.15M | 40.8M | 37.05M | 31.11M | 32.34M | 33.09M | 30.7M | 27.76M | 19.38M |
Interest Expense | 1.55M | 2.18M | 2.77M | 3.19M | 3.09M | 2.85M | 2.61M | 2.31M | 2M | 1.79M | 1.24M | 761K | 357K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -57K | -114K | -114K | -114K | -57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 33.26M | 39.24M | 31.27M | 25.37M | 24.65M | 27.25M | 33.73M | 39.79M | 42.15M | 40.8M | 37.05M | 31.11M | 32.34M | 33.09M | 30.7M | 27.76M | 19.38M |
Income Tax Expense | n/a | 13.72K | 26.91K | 26.91K | -28.09K | -41.81K | -297K | 184K | 643K | 990K | 1.27M | 784K | 377K | 22K | -36K | -35K | -35K |
Shares Outstanding (Basic) | 34.69M | 34.51M | 34.36M | 34.32M | 25.05M | 21.17M | 21.13M | 19.05M | 17.92M | 13.54M | 9.69M | 9.65M | 9.46M | 9.45M | 9.45M | 7.39M | 6.13M |
Shares Outstanding (Diluted) | 34.69M | 34.51M | 34.36M | 34.32M | 25.05M | 21.17M | 21.13M | 19.05M | 17.92M | 13.54M | 9.69M | 9.65M | 9.46M | 9.45M | 9.45M | 7.39M | 6.13M |
EPS (Basic) | -1.37 | -1.26 | -1.13 | -1.11 | -1.29 | -1.53 | -2.08 | -3.14 | -3.84 | -4.18 | -4.13 | -3.44 | -3.84 | -4.3 | -4.31 | -4.74 | -4.89 |
EPS (Diluted) | -1.37 | -1.26 | -1.13 | -1.11 | -1.29 | -1.53 | -2.08 | -3.14 | -3.84 | -4.18 | -4.13 | -3.44 | -3.84 | -4.3 | -4.31 | -4.74 | -4.89 |
EBITDA | -31.79M | -37.42M | -29.95M | -24.08M | -23.91M | -26.65M | -32.63M | -38.95M | -41.53M | -40.33M | -36.76M | -30.85M | -32.09M | -32.87M | -30.47M | -27.53M | -19.13M |
EBIT | -31.97M | -37.65M | -30.17M | -24.35M | -24.22M | -26.96M | -32.96M | -39.23M | -41.76M | -40.56M | -36.99M | -31.09M | -32.33M | -33.12M | -30.72M | -27.79M | -19.39M |
Depreciation & Amortization | 172K | 229K | 228K | 271K | 314K | 315K | 323K | 278K | 234K | 236K | 233K | 239K | 246K | 250K | 252K | 256K | 258K |